Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7934 results

Sort By:

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

Study ID: NCT01530373
Start Date: 2012-02
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

110

Intervention / Treatment

Solifenac

Clonidine

Sponsor

University of Arkansas

Source: clinicaltrials.gov

Share:
Add to list

Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer

Study ID: NCT04605731
Start Date: 2021-08-03
End Date: 2025-08-25
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

Durvalumab

Tremelimumab

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors

Study ID: NCT02956291
Start Date: 2017-02-15
End Date: 2025-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

84

Intervention / Treatment

Magnetic Resonance Fingerprinting

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

Study ID: NCT05888831
Start Date: 2023-06-06
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

BMS-986449

Nivolumab

Sponsor

Bristol-Myers Squibb

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

Study ID: NCT06351631
Start Date: 2024-05-23
End Date: 2034-12-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

State

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors

Study ID: NCT05103631
Start Date: 2021-06-17
End Date: 2039-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

27

Intervention / Treatment

CATCH T cells

Sponsor

Baylor College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06)

Study ID: NCT05002127
Start Date: 2022-01-15
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

450

Intervention / Treatment

Evorpacept (ALX148)

Trastuzumab

Ramsirumb

Paclitaxel

Sponsor

ALX Oncology Inc.

Source: clinicaltrials.gov

Share:
Add to list

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Study ID: NCT04459273
Start Date: 2020-08-27
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Computed Tomography

Gallium Ga 68 FAPi-46

Positron Emission Tomography

18F-FDG

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study With Various Immunotherapy Treatments in Participants With Lung Cancer

Study ID: NCT05676931
Start Date: 2023-02-21
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

400

Intervention / Treatment

Domvanalimab

Quemliclustat

Zimberelimab

Docetaxel

Platinum-Based Doublet

Sponsor

Gilead Sciences

Source: clinicaltrials.gov

Share:
Add to list

Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Study ID: NCT06608927
Start Date: 2024-12-13
End Date: 2030-11-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

610

Intervention / Treatment

Quemliclustat

Placebo

Nab-paclitaxel

Gemcitabine

Sponsor

Arcus Biosciences, Inc.

Source: clinicaltrials.gov

Share:
Add to list